We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Xtant Medical Holdings Inc | AMEX:XTNT | AMEX | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.03 | -4.00% | 0.72 | 0.7596 | 0.72 | 0.73 | 63,711 | 21:15:04 |
From May 2019 to May 2024
Sean Browne, President and Chief Executive Officer, and Greg Jensen, Vice President, Finance and Chief Financial Officer, will host a conference call on Thursday, May 7 at 9:00 AM ET to review results.
Conference DetailsConference Date: Thursday, May 7, 2020 - 9:00 AM ETConference dial-in: 877-407-6184International dial-in: 201-389-0877Conference Call Name: Xtant Medical Q1 2020 Financial ResultsWebcast Registration: Click Here
Following the live call, a replay will be available on the Company’s website, www.xtantmedical.com, under “Investor Info.”
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
Investor Relations Contact
David CareyLazar FINN PartnersPh: 212-867-1762Email: david.carey@finnpartners.com
1 Year Xtant Medical Chart |
1 Month Xtant Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
